by Rakel Apodaca
In a landmark study published this month, our research team has demonstrated that stem cells exposed to precisely tuned quantum light frequencies show a 400% improvement in viability compared to control groups.
Our patented Quantum Hyperlight Technology works by stimulating the mitochondria within stem cells at specific frequencies. This stimulation:
This breakthrough could significantly improve outcomes for patients receiving stem cell therapies for conditions including:
We are now moving into Phase 2 clinical trials, with the goal of bringing this technology to patients within 3-5 years.
Your donations make this research possible. 100% of every dollar goes directly to the lab.